Toxikon Enters New Partnership with Nelson Laboratories

October 31, 2017

We are excited today to share the news that Toxikon has entered a new partnership with Nelson Laboratories, the laboratory division of Sterigenics International. This partnership includes the divestiture of Toxikon Europe to Nelson Laboratories/Sterigenics and the formation of a long-term strategic arrangement between Toxikon USA and Nelson Laboratories/Sterigenics. We will continue to work closely through a master services agreement with Nelson Laboratories and the former Toxikon Europe, which was executed as part of the transaction.

Under this agreement, Nelson Laboratories will outsource their non-core testing services to Toxikon USA, specifically vivo biocompatibility and other related testing services. Toxikon USA will refer specific pharmaceutical extractable and leachable testing customers to the former Toxikon Europe.

Toxikon USA – and the Toxikon brand – will continue to exist. We will increase our ongoing investment in high-quality testing and consulting services. Our analytical chemistry services remain in place, with a focus on new analytical methodologies and an increase in medical device extractable and leachable testing capabilities. All other testing services and capabilities will continue as they do today. Toxikon Europe will transition to the Nelson/Sterigenics brand within 3-6 months.

Together through this collaboration and as partners, we will continue to deliver innovative facilities, methods, and capabilities, and provide our customers the most comprehensive suite of life science product development, testing and follow-on support services available in the market.

As a current Toxikon customer, you will not see any interruption to the work we are performing for you now or in the future. It is our intention to keep our valued customers informed of our activities, as well as any regulatory or scientific updates related to your testing programs.

We invite you to contact us if we can answer any questions to support the safety and efficacy testing of your medical device, pharmaceutical, or combination products.

I thank you all for your support and continued business.


Laxman Desai, D.Sc.
President and Chief Executive Officer
Toxikon Corporation

Toxikon Enters New Partnership with Nelson Laboratories